Treatment with gastric cancer cell CM also increased Smad2/3 expression in Hs738 cells (Fig. s1F), while neutralization with anti-TGF-β1 inhibited these effects accordingly (Fig. s1G). The gene discussed is SMAD2; the disease is gastric cancer.